Lupin launches Varenicline Tablets in US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
NEIAFMR to be developed as the national hub for folk medicine
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Subscribe To Our Newsletter & Stay Updated